Monday, October 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 5, 2026

Asia-Pacific B2B Payments Report 2025-2030: A $1.15 Trillion Market Featuring Leading Competitors - FIS, Fiserv, Bottomline, Coupa, Kyriba, Finastra, HighRadius, Payoneer, Bill.com, Billtrust, Paymate

View original at finance.yahoo.com
Asia-Pacific B2B Payments Report 2025-2030: A $1.15 Trillion Market Featuring Leading Competitors - FIS, Fiserv, Bottomline, Coupa, Kyriba, Finastra, HighRadius, Payoneer, Bill.com, Billtrust, Paymate Company Logo Key market opportunities in APAC B2B payments include catering to SMEs with integrated solutions, leveragi…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • There are more than 100 competitors with revenue greater than $1.0 million in the APAC B2B payments market

    80% confidence
  • Interchange fees account for over 30% of revenue for many B2B payment providers

    80% confidence
  • Primary sectors driving B2B digital payment demand are manufacturing, eCommerce, professional services, IT and technology, and banking and financial services

    80% confidence
  • Payment infrastructure modernization and technology migration will gain momentum over the next 3 to 5 years, driven by regulatory support and customer demand

    80% confidence
  • The revenue estimate for the APAC B2B payments market for base year 2024 is $1.15 trillion

    80% confidence
  • Key market opportunities in APAC B2B payments include catering to SMEs with integrated solutions, leveraging AI for automation, and capitalizing on digitization trends

    80% confidence
  • Automated Finance Platforms are driving transformational growth in B2B payments

    80% confidence
  • The market is characterized by intense competition between traditional banks and fintechs, with the latter disrupting the industry through innovative solutions

    80% confidence
  • The APAC B2B payments market will grow at a CAGR of 9.0% from 2024 to 2030

    80% confidence
  • The top 11 competitors hold only 3.1% revenue share in 2024

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com